Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of January 2024
Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of Jan-05-2024
-
World Rank (Jan-05-2024)5,177Market Cap (Jan-05-2024)2.335 Billion USDWorld Rank (Jul-30-2023)8,660Market Cap (Jul-30-2023)1.015 Billion USDWorld Rank (Dec-25-2022)8,927Market Cap (Dec-25-2022)0.899 Billion USDWorld Rank (Jan-07-2022)8,518Market Cap (Jan-07-2022)1.20 Billion USDAnnual Revenue in USD5 Million USDAnnual Net Income in USD-163 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileCrinetics Pharmaceuticals is a Pharmaceutical company that develops much needed therapies for people with rare endocrine diseases. The company annual revenue is 131.7 million USD and 47 employees. The headquarters is in USA.Company Website
-
Schrodinger Inc.
World Rank (Jan-05-2024)5,184Market Cap (Jan-05-2024)2.332 Billion USDWorld Rank (Jul-30-2023)3,873Market Cap (Jul-30-2023)3.545 Billion USDWorld Rank (Dec-25-2022)7,039Market Cap (Dec-25-2022)1.344 Billion USDWorld Rank (Jan-07-2022)5,797Market Cap (Jan-07-2022)2.26 Billion USDAnnual Revenue in USD180 Million USDAnnual Net Income in USD-149 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileSchrodinger is the scientific leader in developing state of the art chemical simulation software for use in pharmaceutical, Biotechnology and Materials Research company. The headquarters is in USA.
Facts About CompanySchrodinger Annual Total Revenue for year ending Dec-2022 was 180 million USD and and Net loss for year ending Dec-2022 was -149 million USD.
Schrodinger Annual Total Revenue for year ending Dec-2021 was 137 million USD and and Net loss for year ending Dec-2021 was -100 million USD.
As on 2022, Schrodinger has 787 employees.
Company Website -
Recursion Pharmaceuticals Inc.
World Rank (Jan-05-2024)5,212Market Cap (Jan-05-2024)2.314 Billion USDWorld Rank (Jul-30-2023)4,907Market Cap (Jul-30-2023)2.524 Billion USDWorld Rank (Dec-25-2022)6,761Market Cap (Dec-25-2022)1.424 Billion USDWorld Rank (Jan-07-2022)5,259Market Cap (Jan-07-2022)2.67 Billion USDAnnual Revenue in USD40 Million USDAnnual Net Income in USD-239 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileRecursion Pharmaceuticals, Inc. is a clinical stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering to industrialize drug discovery. The company annual revenue is 10 million USD and net loss of 186 Million USD as on 2021. The headquarters is in USA.Company Website -
Arvinas
World Rank (Jan-05-2024)5,263Market Cap (Jan-05-2024)2.279 Billion USDWorld Rank (Jul-30-2023)7,862Market Cap (Jul-30-2023)1.197 Billion USDWorld Rank (Dec-25-2022)5,940Market Cap (Dec-25-2022)1.741 Billion USDWorld Rank (Jan-07-2022)4,198Market Cap (Jan-07-2022)3.65 Billion USDAnnual Revenue in USD131 Million USDAnnual Net Income in USD-282 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileArvinas is a Clinical Stage Biopharmaceutical company. It is focused on developing new therapeutics for cancers and other difficult to treat diseases and on high value targets in cancer including the androgen and estrogen receptors associated with prostate and breast cancers, respectively. The headquarters is in USA.
Company Website -
IDEAYA Biosciences Inc.
World Rank (Jan-05-2024)5,323Market Cap (Jan-05-2024)2.231 Billion USDWorld Rank (Jul-30-2023)7,684Market Cap (Jul-30-2023)1.241 Billion USDWorld Rank (Dec-25-2022)9,463Market Cap (Dec-25-2022)0.819 Billion USDWorld Rank (Jan-07-2022)11,494Market Cap (Jan-07-2022)0.69 Billion USDAnnual Revenue in USD51 Million USDAnnual Net Income in USD-59 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileIDEAYA is a synthetic lethality focused precision medicine oncology company developments and discovery of targeted therapeutics for patient populations selected using molecular diagnostics. The headquarters is in USA.
Facts About CompanyIDEAYA Annual Total Revenue for year ending Dec-2022 was 50 million USD and and Net loss for year ending Dec-2022 was -58 million USD.
IDEAYA Annual Total Revenue for year ending Dec-2021 was 27 million USD and and Net loss for year ending Dec-2021 was -50 million USD.
As on 2022, IDEAYA has 103 employees.
Company Website -
PTC Therapeutics Inc.
World Rank (Jan-05-2024)5,486Market Cap (Jan-05-2024)2.120 Billion USDWorld Rank (Jul-30-2023)4,320Market Cap (Jul-30-2023)3.037 Billion USDWorld Rank (Dec-25-2022)4,471Market Cap (Dec-25-2022)2.661 Billion USDWorld Rank (Jan-07-2022)5,237Market Cap (Jan-07-2022)2.69 Billion USDAnnual Revenue in USD698 Million USDAnnual Net Income in USD-559 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfilePTC Therapeutics is a Commercial and Diversified Biopharmaceutical company. It operates offices and research labs in more than 20 countries and occupy a business footprint in more than 50 countries around the world. It is a having 2,20,000 square feet in Hopewell, New Jersey. The headquarters is in USA.
Company Website -
Indivior
World Rank (Jan-05-2024)5,511Market Cap (Jan-05-2024)2.101 Billion USDWorld Rank (Jul-30-2023)4,222Market Cap (Jul-30-2023)3.140 Billion USDWorld Rank (Dec-25-2022)3,930Market Cap (Dec-25-2022)3.174 Billion USDWorld Rank (Jan-07-2022)5,892Market Cap (Jan-07-2022)2.21 Billion USDAnnual Revenue in USD901 Million USDAnnual Net Income in USD-53 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileIndivior is a global pharmaceutical company working to help change patients lives by pioneering life transforming treatment for substance use disorders and other serious mental illnesses. The company annual revenue is 647 million USD and total assets are 1,531 million USD as on 2020. The headquarters is in UK.
-
Ironwood Pharmaceuticals
World Rank (Jan-05-2024)5,787Market Cap (Jan-05-2024)1.938 Billion USDWorld Rank (Jul-30-2023)6,318Market Cap (Jul-30-2023)1.717 Billion USDWorld Rank (Dec-25-2022)5,616Market Cap (Dec-25-2022)1.899 Billion USDWorld Rank (Jan-07-2022)6,432Market Cap (Jan-07-2022)1.93 Billion USDAnnual Revenue in USD410 Million USDAnnual Net Income in USD175 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileIronwood Pharmaceuticals is a Healthcare company. The headquarters is in USA.Company Website -
Dynavax Technologies Corporation
World Rank (Jan-05-2024)5,790Market Cap (Jan-05-2024)1.936 Billion USDWorld Rank (Jul-30-2023)6,079Market Cap (Jul-30-2023)1.826 Billion USDWorld Rank (Dec-25-2022)6,923Market Cap (Dec-25-2022)1.377 Billion USDWorld Rank (Jan-07-2022)7,127Market Cap (Jan-07-2022)1.62 Billion USDAnnual Revenue in USD722 Million USDAnnual Net Income in USD293 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileDynavax Technologies Corporation is a Fully Integrated Biopharmaceutical company focused on leveraging the power of the body's innate and adaptive immune responses through Toll like Receptor (TLR) stimulation. The headquarters is in USA.Facts About CompanyThe company annual revenue is 46.55 million USD and 249 employees as on 2020.Company Website -
Summit Therapeutics
World Rank (Jan-05-2024)5,892Market Cap (Jan-05-2024)1.889 Billion USDWorld Rank (Jul-30-2023)6,946Market Cap (Jul-30-2023)1.479 Billion USDWorld Rank (Dec-25-2022)15,677Market Cap (Dec-25-2022)0.302 Billion USDWorld Rank (Jan-07-2022)17,453Market Cap (Jan-07-2022)0.26 Billion USDAnnual Revenue in USD1 Million USDAnnual Net Income in USD-79 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany Website